CathVision

About

CathVision is a medical technology company based in Copenhagen, Denmark, with a U.S. office in Minnetonka, Minnesota. Founded in 2013, the company specializes in electrophysiology solutions for diagnosing and treating cardiac arrhythmias, particularly atrial fibrillation. CathVision develops innovative EP recording systems and AI-based analytic tools that provide high-fidelity cardiac electrograms, helping physicians make informed clinical decisions and improve ablation therapy outcomes. The company's primary product is the ECGenius™ System, which features proprietary low-noise hardware for capturing clear cardiac signals and the CARDIALYTICS™ suite for real-time analytics. This system enhances the measurement, analysis, and recording of pacing signals, making it a preferred choice over legacy systems in many electrophysiology labs. CathVision has raised nearly $30 million in funding to support its growth and has completed several clinical studies, including a partnership with NYU Langone Health to advance its technology.